Krings, Amrei
Steffen, Gyde
Zimmermann, Ruth
,
Funding for this research was provided by:
German Federal Ministry of Health (2520AUK701, 2520AUK701)
Robert Koch-Institut
Article History
Received: 1 November 2023
Accepted: 27 February 2024
First Online: 14 March 2024
Declarations
:
: Ethical approval for the DRUCK 2.0 study, including the evaluation, was provided by the Medical Chamber Berlin (ETH-51/10). Study participants provided their written informed consent.
: AK: none. GS: none. RZ: none. Study group: Condrobs, employer of Olaf Ostermann, cooperates with abbvie and gilead. No conflict of interest declared by the other study group members.